Martina Hahn

12PUBLICATIONS
33CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Behavioural geneticsGene expression (incl. microarray and other genome-wide approaches)Clinical pharmacy and pharmacy practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 02, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

|Jun 26, 2026
Preliminary Evidence for Sex Differences in CYP2C19 Metabolic Capacity During Psychotropic Drug Treatment.

|Apr 29, 2026
CYPRI: a clinical decision-making tool to select psychiatric patients for pharmacogenetic testing.

|Apr 09, 2026
Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study.

Carolin Görnert, Maike Scherf-Clavel, Heike Weber

|Dec 30, 2025
An Exploratory, Retrospective Study of the CYPRI Score for Pharmacogenetic Testing Among Mental Health Patients.

Samira Marie Comtesse, Ivana Tašková, Nicole Safářová

|Oct 30, 2024
[Correction: Pharmacogenetic testing to optimize psychopharmacotherapy: Case study of a patient with severe depression and lack of treatment success due to genetic polymorphisms for CYP2D6 and CYP2C19].

Andreas Philipp Eckert, Martina Hahn

Pageof 2

Frequent Collaborators

3 joint publications

Maike Scherf-Clavel

2 joint publications

Andreas Reif

2 joint publications

Ivana Tašková

2 joint publications

Heike Weber